Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Migraine

Free Subscription 26.02.2024 1 Cephalalgia 5 Headache 4 Lancet Neurol

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Cephalalgia

1. VIANA M, Hougaard A, Tronvik E, Winnberg IG, et al
   Visual migraine aura iconography: A multicentre, cross-sectional study of individuals with migraine with aura.
   Cephalalgia. 2024;44:3331024241234809.
   PubMed         Abstract available
   
   

   
   Headache

2. ROSSIGNOL J, Ouimet T, Poras H, Dallel R, et al
   Synergistic effect of combining dual enkephalinase inhibitor PL37 and sumatriptan in a preclinical model of migraine.
   Headache. 2024 Feb 22. doi: 10.1111/head.14681.
   PubMed         Abstract available
   
   
3. LANGDON RL, DiSabella MT, Strelzik JA
   Screen time and pediatric headache: A scoping review of the literature.
   Headache. 2024;64:211-225.
   PubMed         Abstract available
   
   
4. HAN C, Lim JY, Koike N, Kim SY, et al
   Regulation of headache response and transcriptomic network by the trigeminal ganglion clock.
   Headache. 2024;64:195-210.
   PubMed         Abstract available
   
   
5. JICHA C, Pham K
   Neuromodulation for primary headache disorders: Advantages and challenges.
   Headache. 2024;64:226-228.
   PubMed        
   
   
6. PRADHAN SK, Gantenbein AR, Li Y, Shaban H, et al
   Daith piercing: Revisited from the perspective of auricular acupuncture systems. A narrative review.
   Headache. 2024;64:131-140.
   PubMed         Abstract available
   
   

   
   Lancet Neurol

7. CHIANG CC, Porreca F, Robertson CE, Dodick DW, et al
   Potential treatment targets for migraine: emerging options and future prospects.
   Lancet Neurol. 2024;23:313-324.
   PubMed         Abstract available
   
   
8. HAY DL
   A future treatment horizon for migraine?
   Lancet Neurol. 2024;23:226-227.
   PubMed        
   
   
9. TASSORELLI C, Nagy K, Pozo-Rosich P, Lanteri-Minet M, et al
   Safety and efficacy of atogepant for the preventive treatment of episodic migraine in adults for whom conventional oral preventive treatments have failed (ELEVATE): a randomised, placebo-controlled, phase 3b trial.
   Lancet Neurol. 2024 Feb 13:S1474-4422(24)00025.
   PubMed         Abstract available
   
   
10. XU X, Dong L, Zhou J
    ELEVATEd hope for patients after migraine treatment failure.
    Lancet Neurol. 2024 Feb 13:S1474-4422(24)00072.
    PubMed        
    
    

Thank you for your interest in scientific medicine.

AMEDEO Migraine is free of charge.